0001140361-24-032091.txt : 20240702 0001140361-24-032091.hdr.sgml : 20240702 20240702091545 ACCESSION NUMBER: 0001140361-24-032091 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240628 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240702 DATE AS OF CHANGE: 20240702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARYA Sciences Acquisition Corp IV CENTRAL INDEX KEY: 0001838821 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40122 FILM NUMBER: 241093065 BUSINESS ADDRESS: STREET 1: 51 ASTOR PLACE, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 212-284-2300 MAIL ADDRESS: STREET 1: 51 ASTOR PLACE, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 8-K 1 ny20020899x28_8k.htm FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 28, 2024
ARYA SCIENCES ACQUISITION CORP IV
(Exact name of registrant as specified in its charter)
Cayman Islands
001-40122
98-1574672
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
     
51 Astor Place, 10th Floor
New York, NY
10003
(Address of principal executive offices)
(Zip Code)

(212) 284-2300
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
☒
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Class A Ordinary Shares, par value $0.0001 per share
ARYD
The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01.     Entry into a Material Definitive Agreement.
On June 28, 2024, ARYA Sciences Acquisition Corp IV (the “Company”) issued an unsecured convertible promissory note (the “Fifth Convertible Promissory Note”) to ARYA Sciences Holdings IV (the “Sponsor”), pursuant to which the Company may borrow $150,000 (the “Working Capital Loan”) from the Sponsor for general corporate purposes and the funding of the deposits required to be made into the Company’s trust account in connection with the monthly extensions of the time period during which the Company may consummate a Business Combination (as defined below) in accordance with the Company’s amended and restated memorandum and articles of association, as amended from time to time. Such loan may, at the Sponsor’s discretion, be converted into the Company’s Class A ordinary shares, par value $0.0001 per share (the “Working Capital Shares”), at a conversion price equal to $10.00 per Working Capital Share.
The terms of the Working Capital Shares will be identical to those of the private placement shares that were issued to the Sponsor in connection with the Company’s initial public offering that was consummated on March 2, 2021. The Working Capital Loan will not bear any interest and will be repayable by the Company to the Sponsor, if not converted or repaid, on the effective date of an initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Company and one or more businesses (a “Business Combination”). In the event that the Company does not consummate a Business Combination, the Fifth Convertible Promissory Note will be repaid from funds held outside of the Company’s trust account, or will be forfeited, elimited or otherwise forgiven. The maturity date of the Working Capital Loan may be accelerated upon the occurrence of an Event of Default (as defined under the Fifth Convertible Promissory Note).
The foregoing description of the Fifth Convertible Promissory Note does not purport to be complete and is qualified in its entirety by the terms and conditions of thereof. A copy of the Fifth Convertible Promissory Note is attached hereto as Exhibit 10.1 and incorporated herein by reference.
Item 2.03.     Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement or a Registrant.
The information disclosed under Item 1.01 and Item 8.01 of this Current Report on Form 8-K (the “Current Report”) is incorporated by reference into this Item 2.03 to the extent required herein.
Item 8.01.     Other Events.
On July 2, 2024, the Company approved the fourth one-month extension of the time period during which it may consummate an initial business combination (such time period, the “Business Combination Period”). In connection with this extension of the Business Combination Period to August 2, 2024 (the “Extension”), the Company drew an aggregate of $111,000 (the “Extension Funds”) from the Fifth Convertible Promissory Note. As provided for in the Company’s amended and restated memorandum and articles of association (as amended, the “A&R Memorandum and Articles of Association”), the Company will deposit the Extension Funds into the trust account that was established by the Company in connection with its initial public offering (the “Trust Account”). The Company also drew $24,000 under the Fifth Convertible Promissory Note for general working capital purposes. The Extension is the fourth one-month extension currently permitted under the A&R Memorandum and Articles of Association.
The foregoing description of the Fifth Convertible Promissory Note is qualified in its entirety by reference to the description thereof included in Item 1.01 of this Current Report.
Item 9.01.     Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
  
Description
 
Fifth Convertible Promissory Note, dated June 28, 2024 and issued to ARYA Sciences Holdings IV.
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document).
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: July 2, 2024
 ARYA SCIENCES ACQUISITION CORP IV

   
  By:
/s/ Michael Altman
  Name: Michael Altman
  Title:
Chief Financial Officer

4
EX-10.1 2 ny20020899x28_ex10-1.htm EXHIBIT 10.1
Exhibit 10.1
THIS CONVERTIBLE PROMISSORY NOTE (THIS “NOTE”) AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE. THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE MAKER MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE MAKER TO THE EFFECT THAT ANY SALE OR OTHER DISPOSITION IS IN COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
CONVERTIBLE PROMISSORY NOTE
Total Principal Amount: up to $150,000
(as set forth on the Schedule of Borrowings attached hereto)
Dated as of June 28, 2024
FOR VALUE RECEIVED and subject to the terms and conditions set forth herein, ARYA Sciences Acquisition Corp IV, a Cayman Islands exempted company and blank check company (the “Maker”), promises to pay to the order of ARYA Sciences Holdings IV, a Cayman Islands exempted company, or its registered assigns or successors in interest (the “Payee”), or order, the principal sum of up to one hundred fifty thousand U.S. dollars ($150,000) (as set forth on the Schedule of Borrowings attached hereto) in lawful money of the United States of America, on the terms and conditions described below. All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note.
1. Principal. The principal balance of this Note (the “Total Principal Amount”) shall be payable by the Maker on the effective date of the consummation of the Maker’s initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”, and such date, the “Maturity Date”), unless accelerated upon the occurrence of an Event of Default (as defined below). Any principal balance under the Note may be prepaid at any time; provided, however, that the Payee shall have a right to first convert such balance pursuant to Section 8 hereof upon notice of such prepayment. Under no circumstances shall any individual, including but not limited to any officer, director, employee or shareholder of the Maker, be obligated personally for any obligations or liabilities of the Maker hereunder. The Payee understands that if a Business Combination is not consummated, this Note will be repaid solely to the extent that the Maker has funds available to it outside of its trust account established in connection with its initial public offering of its securities (the “Trust Account” and such offering, the “IPO”), and that all other amounts will be contributed to capital, forfeited, eliminated or otherwise forgiven or eliminated.
2. Interest. No interest shall accrue on the unpaid principal balance of this Note.
3. Drawdown Requests. The Maker and the Payee agree that the Maker may request up to one hundred fifty thousand U.S. dollars ($150,000) under this Note. The principal of this Note may be drawn down from time to time prior to the effective date of the Business Combination, upon written request from the Maker to the Payee (each, a “Drawdown Request”). Each Drawdown Request must be for $111,000 or such other amount agreed upon by the Maker and the Payee. Payee shall fund each Drawdown Request no later than five (5) business days after receipt of a Drawdown Request. Once an amount is drawn down under this Note, it shall not be available for future Drawdown Requests even if prepaid. No fees, payments or other amounts shall be due to the Payee in connection with, or as a result of, any Drawdown Request by the Maker.
4. Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal balance of this Note.
5. Purpose. The Maker shall apply all the amounts advanced by the Payee under this Note towards the Maker’s general working capital requirements or deposits that Maker is required to make pursuant to its amended and restated memorandum and articles of association (as amended and/or restated from time to time) and following the request of Payee in connection with an optional monthly extension of the time period during which Maker may consummate a Business Combination.
6. Events of Default. Each of the following shall constitute an event of default (“Event of Default”):
(a) Failure to Make Required Payments. Failure by the Maker to pay all or a portion of the Total Principal Amount due pursuant to this Note (to the extent such amount is payable in cash) within five (5) business days of the Maturity Date and/or, if applicable, failure by the Maker to perform its obligations with respect to the conversion of up to the Total Principal Amount of this Note, in whole or in part at the option of the Payee, into Private Placement Shares pursuant to Section 5 hereof.
(b) Voluntary Bankruptcy, Etc. The commencement by the Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) of the Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of the Maker generally to pay its debts as such debts become due, or the taking of corporate action by the Maker in furtherance of any of the foregoing.
(c) Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of the Maker in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of the Maker or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of sixty (60) consecutive days.
7. Remedies.
(a) Upon the occurrence of an Event of Default specified in Section 6(a) hereof, the Payee may, by written notice to the Maker, declare this Note to be due immediately and payable, whereupon the unpaid Total Principal Amount of this Note, and all other amounts payable hereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.
(b) Upon the occurrence of an Event of Default specified in Sections 6(b) and 6(c), the unpaid principal balance of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee.
2
8. Conversion.
(a) Optional Conversion. Upon consummation of a Business Combination, the Payee shall have the option, but not the obligation, to convert up to the Total Principal Amount of this Note, in whole or in part at the option of the Payee, into Class A ordinary shares in the capital of the Maker (each, an “Ordinary Share”), at a conversion price of $10.00 per Ordinary Share. The Ordinary Shares shall be identical to the private placement shares issued to the Sponsor at the time of the Maker’s IPO (the “Private Placement Shares”). As promptly as reasonably practicable after notice by the Payee to the Maker to convert the principal balance of this Note, in whole or in part, into Private Placement Shares, which notice must be made at least five (5) business days prior to the consummation of the Business Combination, and after the Payee’s surrender of this Note, the Maker shall have issued and delivered to the Payee, without any charge to the Payee, a share certificate or certificates (issued in the name(s) requested by the Payee), or shall have made appropriate book-entry notation on the books and records of the Maker, in each case for the number of Private Placement Shares of the Maker issuable upon the conversion of this Note. The conversion shall be deemed to have been made immediately prior to the close of business on the date of the surrender of this Note and the person or persons entitled to receive the Private Placement Shares upon such conversion shall be treated for all purposes as the record holder or holders of such Private Placement Shares as of such date. Each such newly issued Private Placement Share shall include a restricted legend that contemplates the same restrictions as the Private Placement Shares that were issued to Payee in connection with the IPO. The Private Placement Shares issuable pursuant to this Note shall constitute “Registrable Securities” pursuant to that certain Registration and Shareholder Rights Agreement, dated March 2, 2021, by and among the Maker, the Payee and certain other security holders named therein.
(b) Fractional Shares; Effect of Conversion. No fractional Private Placement Shares shall be issued upon conversion of this Note. In lieu of any fractional Private Placement Shares to the Payee upon conversion of this Note, the Maker shall pay to the Payee an amount equal to the product obtained by multiplying the Conversion Price by the fraction of a Private Placement Share not issued pursuant to the previous sentence. Upon conversion of this Note in full, this Note shall be cancelled and void without further action of the Maker or the Payee, and the Maker shall be forever released from all its obligations and liabilities under this Note.
9. Covenants of the Maker. The Maker covenants that any Private Placement Shares issuable upon conversion of the Note, when so issued, will be validly issued, fully paid and non-assessable and free from all taxes, liens and charges with respect to the issuance thereof.
10. Waivers. The Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by the Payee under the terms of this Note, and all benefits that might accrue to the Maker by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and the Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by the Payee.
11. Unconditional Liability. The Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by the Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by the Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to the Maker or affecting the Maker’s liability hereunder.
3
12. Notices. All notices, statements or other documents which are required or contemplated by this Note shall be: (i) in writing and delivered personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax number as may be designated in writing by such party or (iii) by electronic mail, to the electronic mail address most recently provided to such party or such other electronic mail address as may be designated in writing by such party. Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days after mailing if sent by mail.
13. Construction. THIS NOTE SHALL BE GOVERNED AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.
14. Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
15. Trust Waiver. Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”) in or to any monies in, or any distribution of or from, the Trust Account, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Payee hereby agrees not to make any Claim against the Trust Account (including any distributions therefrom), regardless of whether such Claim arises as a result of, in connection with or relating in any way to, this Note, or any other matter, and regardless of whether such Claim arises based on contract, tort, equity or any other theory of legal liability. To the extent the Payee commences any action or proceeding based upon, in connection with, relating to or arising out of any matter relating to the Maker (including this Note), which proceeding seeks, in whole or in part, monetary relief against the Maker, the Payee hereby acknowledges and agrees that its sole remedy shall be against funds held outside of the Trust Account and that such Claim shall not permit the Maker (or any person claiming on its behalf or in lieu of it) to have any Claim against the Trust Account (including any distributions therefrom) or any amounts contained therein.
16. Tax Treatment. In each case for U.S. federal income tax and all other applicable tax purposes, the Maker and the Payee agree to treat this Note as an equity interest in the Maker (and not as indebtedness), and shall take no contrary position on any tax return or before any taxing authority (unless otherwise required by law). The Maker and the Payee shall reasonably cooperate to structure (i) any conversion of this Note in connection with a Business Combination and (ii) any contribution, forfeiture or elimination of this Note pursuant to Section 1 in a manner that is tax-efficient for the Maker and the Payee, taking into account the terms of any Business Combination.
4
17. Amendment; Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of the Maker and the Payee.
18. Successors and Assigns. Subject to the restrictions on transfer in Section 18 and Section 19, the rights and obligations of the Maker and the Payee hereunder shall be binding upon and benefit the successors, assigns, heirs, administrators and transferees of any party hereto (by operation of law or otherwise) with the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void.
19. Transfer of this Note or Securities Issuable on Conversion. With respect to any sale or other disposition of this Note or securities into which this Note may be converted, the Payee shall give written notice to the Maker prior thereto, describing briefly the manner thereof, together with (i) except for a Permitted Transfer, in which case the requirements in (i) shall not apply, (A) a written opinion (unless waived by the Maker) reasonably satisfactory to the Maker in form and substance from counsel reasonably satisfactory to the Maker to the effect that such sale or other distribution may be effected without registration or qualification under any U.S. federal or state law then in effect and (B) a written opinion from counsel reasonably satisfactory to the Maker or a certificate signed by at least one director of the Payee (in either case, unless waived by the Maker), reasonably satisfactory to the Maker in form and substance that such sale or other distribution does not violate, contravene, or result in a default by the Payee of, any agreement or instrument entered into by the Payee in connection with the IPO or the Business Combination, including but not limited to the Letter Agreement (as defined below), and (ii) a written undertaking executed by the desired transferee reasonably satisfactory to the Maker in form and substance agreeing to be bound by the restrictions on transfer contained herein. Upon receiving such written notice, reasonably satisfactory opinion and/or certificate (unless waived by the Maker), or other evidence, and such written acknowledgement, the Maker, as promptly as practicable, shall notify the Payee that the Payee may sell or otherwise dispose of this Note or such securities, all in accordance with the terms of the note delivered to the Maker. If a determination has been made pursuant to this Section 19 that the opinion of counsel for the Payee, the certificate of the Payee, or other evidence, or the written acknowledgment from the desired transferee, is not reasonably satisfactory to the Maker,  the Maker shall so notify the Payee promptly after such determination has been made. Each Note thus transferred shall bear a legend as to the applicable restrictions on transferability in order to ensure compliance with the Securities Act, unless in the opinion of counsel for the Maker such legend is not required in order to ensure compliance with the Securities Act. The Maker may issue stop transfer instructions to its transfer agent in connection with such restrictions. Subject to the foregoing, transfers of this Note shall be registered upon registration on the books maintained for such purpose by or on behalf of the Maker. Prior to presentation of this Note for registration of transfer, the Maker shall treat the registered holder hereof as the owner and holder of this Note for the purpose of receiving all payments of principal hereon and for all other purposes whatsoever, whether or not this Note shall be overdue and the Maker shall not be affected by notice to the contrary. For purposes hereof, “Permitted Transfer” shall have the same meaning as any transfer that would be permitted for the Private Placement Shares under the Letter Agreement, dated February 25, 2021, by and among the Maker, the Payee and the other parties thereto (the “Letter Agreement”).
20. Acknowledgment. The Payee is acquiring this Note for investment for its own account, not as a nominee or agent, and not with a view to, or for resale in connection with, any distribution thereof in violation of applicable securities laws. The Payee understands that the acquisition of this Note involves substantial risk. The Payee has experience as an investor in securities of companies and acknowledges that it is able to fend for itself, can bear the economic risk of its investment in this Note, and has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of this investment in this Note and protecting its own interests in connection with this investment.
[Remainder of Page Intentionally Left Blank]
5
IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed by the undersigned as of the day and year first above written.
 
 ARYA Sciences Acquisition Corp IV
   
  By:
 /s/ Michael Altman
 
Name: Michael Altman

Title: Chief Financial Officer
Agreed and Acknowledged as of the date first written above:
ARYA Sciences Holdings IV
By:
 /s/ Sam Cohn
 
Name: Sam Cohn  
Title: Secretary

[Signature Page to Fifth Promissory Note]
SCHEDULE OF BORROWINGS
The following increases or decreases in this Promissory Note have been made:
Date of Increase or Decrease
  
Amount of decrease in Principal Amount of this Promissory Note
  
Amount of increase in Principal Amount of this Promissory Note
  
Principal Amount of this Promissory Note following such decrease or increase


EX-101.SCH 3 aryd-20240628.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 aryd-20240628_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Ex Transition Period Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 aryd-20240628_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Document and Entity Information
Jun. 28, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 28, 2024
Entity File Number 001-40122
Entity Registrant Name ARYA SCIENCES ACQUISITION CORP IV
Entity Central Index Key 0001838821
Entity Incorporation, State or Country Code E9
Entity Tax Identification Number 98-1574672
Entity Address, Address Line One 51 Astor Place, 10th Floor
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10003
City Area Code 212
Local Phone Number 284-2300
Title of 12(b) Security Class A Ordinary Shares, par value $0.0001 per share
Trading Symbol ARYD
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Written Communications true
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( /5)XE@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #U2>)8_X7?WN\ K @ $0 &1O8U!R;W!S+V-O&ULS9++ M:L,P$$5_I6AOCVSWA7"\:+3I*4)45L&Z> M&(YCW\(%,,,(HTW?!=0+,5?_Q.8.L%-R3&9)#<-0#DW.33M4\/;T^)+7+8Q+ M))W"Z5&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" #U2>)88>+G88H$ !,$0 & 'AL+W=O3=OI!V (\9UNN+ ?R M[[LRQ*9W9LT7L+#U^M%J]:[$<"O5MWPCA":[)$[SD;71.KNU[3S8B(3GES(3 M*=Q9295P#4VUMO-,"1Z6G9+89HYS92<\2JWQL/QMKL9#6>@X2L5 M[T0LMR.+6F\_/$7KC38_V.-AQM?"%_IS-E?0LBN5,$I$FDQ"UJG>: MCL?7;^H/Y>!A,$N>"T_&7Z-0;T;6P"*A6/$BUD]R^X<\U'P^5W!)EG@8U MP-<%%J9L77"NY&T$^/[V500) UX6E()JF.]"N9IOO9AJ@-;0TO,8_: MP4'P;B_(3@C^6:27A TZA#FL]__N-K!5@*P"9*5>]X2>)U^$(G^[RUPKF,)_ MFHCV"KUF!9/7MWG& S&R('%SH5Z$-?[E)WKE_([P=2N^+J9>!W#QFHDF.+S[ MX.(] M&K('JHB@L$84GQ$/-U$P7>?\7C7" <_8JC?UXPYD)%TB142" M&^." M*U5IU)9'5Q7:%2IXR.V'*!9D5B1+H9J@< W'H1<]AS*&\%Q7/-?G\#R)=60R M&V(VXTECH' =]^G9);XWGG7,8%WQ'IB'$+UI%00F*)&&+Y,W@@O:O>U?7 M6!K2HP) SR%TPQ#,,>^\79 /\!QY3!M#UR+9I\2%RJ7(/ ;;[1#JZ TXDY0* M(ZXK D4-_0=BS[3@;0NY;2Y8N-P,M@[/L'7 V.IJ0'$__YZMRL:YDB]1&C2' M$]>4G5PB+8H4EG,78ZOK!L7MOIQ"%[:5IU%P M 4;1U5!7"8I;_ <90$SF&YEB9:)%A UZ%ZSK.!A172_=S]A^]NZ1+"S2L0D$6IMHO0.%, O/9ED/&V(A:NU;3+9T9$ =^RO,(5:I"9$29$>"FK>B(0+M46J MMGV&6[0OXRB ^,#T?03#5Q%O3/,6E=8(U5[/<&>>*W$10'0$5)S]Z00."+"F M'U>K9D=KT6LEJYV>X4;] ]DTSPL@:P7$94\"VD=G8_,_PT=N5EE.8K$"(>?R M&G35_NB^;VB9E&ULW5=M:]LP$/XK M0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZ MNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y M*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB6 M2;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9 M,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8 MDMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J* MW5B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%PZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/ M[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*P MG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0ERHY M_U=3_ 102P,$% @ ]4GB6)>*NQS $P( L !?3T\ M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5* M(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_')8'#AEZC\! \ @ #P 'AL M+W=OFR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2* MY U+2X3[+O,&@EXN1:T/9=1,92L88!.R '<(Y_A^[<#K3P&]'@!6^AC(,=D",Y1]XVXG\ M-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=R_$)'0.M#,,SQ;;!<.AHQ$5V M9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D&IND53 >"CVN*!.L>@PL(:EU M&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&L&]R( DNR94;4EWI>::W=Y-[ M2:AU[D&P]_ :C1W-CQ^W_ %02P,$% @ ]4GB6"0>FZ*M ^ $ !H M !X;"]?+7_OR4Z?:!1W;J"V\R1&:P;*9,OL M[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C] MLCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP M3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0 ( /5)XEAED'F2&0$ ,\# M 3 6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@ M"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0" M50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M- M\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[ M0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TF MGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D)8_X7?WN\ K @ $0 M @ &O 9&]C4')O<',O8V]R92YX;6Q02P$"% ,4 " #U2>)8F5R< M(Q & "<)P $P @ '- 0 >&PO=&AE;64O=&AE;64Q+GAM M;%!+ 0(4 Q0 ( /5)XEAAXN=AB@0 $P1 8 " @0X( M !X;"]W;W)K)8GZ ; M\+$" #B# #0 @ '.# >&PO)8)!Z;HJT M #X 0 &@ @ '_$0 >&PO7W)E;',O=V]R:V)O;VLN>&UL M+G)E;'-02P$"% ,4 " #U2>)899!YDAD! #/ P $P M@ 'D$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" N% " ! end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2 html 1 23 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://perceptivelife.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports aryd-20240628.xsd aryd-20240628_lab.xml aryd-20240628_pre.xml ny20020899x28_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ny20020899x28_8k.htm": { "nsprefix": "aryd", "nsuri": "http://perceptivelife.com/20240628", "dts": { "schema": { "local": [ "aryd-20240628.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "labelLink": { "local": [ "aryd-20240628_lab.xml" ] }, "presentationLink": { "local": [ "aryd-20240628_pre.xml" ] }, "inline": { "local": [ "ny20020899x28_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 30, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://perceptivelife.com/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20240628to20240628", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20020899x28_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20240628to20240628", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ny20020899x28_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001140361-24-032091-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-24-032091-xbrl.zip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end XML 17 ny20020899x28_8k_htm.xml IDEA: XBRL DOCUMENT 0001838821 2024-06-28 2024-06-28 false 0001838821 NASDAQ 8-K 2024-06-28 ARYA SCIENCES ACQUISITION CORP IV E9 001-40122 98-1574672 51 Astor Place, 10th Floor New York NY 10003 212 284-2300 true false false false Class A Ordinary Shares, par value $0.0001 per share ARYD true false